4-[4-(Furan-2-carbonyl)piperazin-1-yl]-4-oxobutanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-[4-(Furan-2-carbonyl)piperazin-1-yl]-4-oxobutanoic acid
• 化学式: C₁₃H₁₆N₂O₅
• mdl: MFCD00426519
• 分子量: 280.28
• InChiKey: PNEQJCQAOHOSJW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  91.1
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• 1, 3-DIAMINO-2-HYDROXYPROPANE PRODRUG DERIVATIVES
  申请人：Elan Pharmaceuticals, Inc.

  公开号：EP1534693A2

  公开（公告）日：2005-06-01
• [EN] 1, 3-DIAMINO-2-HYDROXYPROPANE PRODRUG DERIVATIVES<br/>[FR] DERIVES DE PROMEDICAMENTS A BASE DE 1, 3-DIAMINO-2-HYDROXYPROPANE
  申请人：ELAN PHARM INC

  公开号：WO2004022523A2

  公开（公告）日：2004-03-18

  The present invention relates to compounds of formula (AA), (I) and (X), useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.